Cargando…

Immunogenicity Analysis of PCV3 Recombinant Capsid Protein Virus-like Particles and Their Application in Antibodies Detection

Porcine circovirus type 3 is a newly emerging pathogen of porcine circovirus associated disease (PCVAD). Currently, there is no commercially available vaccine, resulting in huge economic losses to the pig industry. Porcine circovirus type 3 capsid protein (Cap) can self-assemble into virus-like part...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Xuyang, Huang, Min, Wang, Ying, Chen, Yanzhi, Yang, Hanwen, Quan, Fusheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299735/ https://www.ncbi.nlm.nih.gov/pubmed/37373524 http://dx.doi.org/10.3390/ijms241210377

Ejemplares similares

Self-assembly into virus–like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection
por: Wang, Yu, et al.
Publicado: (2020)

Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein
por: Zhou, Yong-Fei, et al.
Publicado: (2022)

Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope
por: Mo, Xiaobing, et al.
Publicado: (2019)

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography
por: Huhti, L., et al.
Publicado: (2012)

Immunogenicity of Pigeon Circovirus Recombinant Capsid Protein in Pigeons
por: Stenzel, Tomasz, et al.
Publicado: (2018)

Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs
por: Cao, Yimei, et al.
Publicado: (2009)

Recombinant expression of beak and feather disease virus capsid protein and assembly of virus-like particles in Nicotiana benthamiana
por: Regnard, Guy L., et al.
Publicado: (2017)

Cloning, expression & evaluation of potential immunogenic recombinant capsid premembrane protein of West Nile virus
por: Kumar, Jyoti S., et al.
Publicado: (2019)

Immunogenicity and Protective Activity of Pigeon Circovirus Recombinant Capsid Protein Virus-Like Particles (PiCV rCap-VLPs) in Pigeons (Columba livia) Experimentally Infected with PiCV
por: Huang, Huai-Ying, et al.
Publicado: (2021)

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration
por: Janitzek, Christoph M., et al.
Publicado: (2021)

Virus-Like Particles Produced Using the Brome Mosaic Virus Recombinant Capsid Protein Expressed in a Bacterial System
por: Strugała, Aleksander, et al.
Publicado: (2021)

Development of an indirect ELISA based on recombinant capsid protein to detect antibodies to bovine leukemia virus
por: Andreolla, Ana Paula, et al.
Publicado: (2018)

Modification of PCV-2 virulence by substitution of the genogroup motif of the capsid protein
por: Allemandou, Aude, et al.
Publicado: (2011)

Immunogenicity and Antigenicity of Rabbit Hepatitis E Virus-Like Particles Produced by Recombinant Baculoviruses
por: Bai, Huimin, et al.
Publicado: (2021)

Immunogenicity and Immunoprotection of PCV2 Virus-like Particles Incorporating Dominant T and B Cell Antigenic Epitopes Paired with CD154 Molecules in Piglets and Mice
por: Wu, Keke, et al.
Publicado: (2022)

Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies
por: Nainys, Juozas, et al.
Publicado: (2014)

A Sandwich ELISA for Quality Control of PCV2 Virus-like Particles Vaccine
por: Sun, Mingxia, et al.
Publicado: (2022)

Structure, Antigenic Properties, and Highly Efficient Assembly of PCV4 Capsid Protein
por: Wang, Dongliang, et al.
Publicado: (2021)

Evaluation of a Virus-like Nanoparticle Porcine Circovirus Type-2 (PCV2) Capsid Protein Fused with the Pig Immunoglobulin Fc Fragment as a Novel Vaccine Candidate against PCV2 in Mice
por: Luo, Qingping, et al.
Publicado: (2021)

Influence of Dosing Regimen and Adjuvant Type on the Immunogenicity of Novel Recombinant Zika Virus-Like Particles
por: Brzuska, Gabriela, et al.
Publicado: (2022)

Self-assembly of dengue virus empty capsid-like particles in solution
por: Neves-Martins, Thais C., et al.
Publicado: (2023)

Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice
por: Ma, Fenlian, et al.
Publicado: (2023)

Novel Capsid-Specific Single-Domain Antibodies with Broad Foot-and-Mouth Disease Strain Recognition Reveal Differences in Antigenicity of Virions, Empty Capsids, and Virus-Like Particles
por: Li, Haozhou, et al.
Publicado: (2021)

Functional exchangeability of the nuclear localization signal (NLS) of capsid protein between PCV1 and PCV2 in vitro: Implications for the role of NLS in viral replication
por: Shuai, Jiangbing, et al.
Publicado: (2011)

Assembly of Recombinant Israeli Acute Paralysis Virus Capsids
por: Ren, Junyuan, et al.
Publicado: (2014)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

The Construction and Immunogenicity Analyses of Recombinant Pseudorabies Virus With NADC30-Like Porcine Reproductive and Respiratory Syndrome Virus-Like Particles Co-expression
por: Zhao, Jun, et al.
Publicado: (2022)

Capsid and Infectivity in Virus Detection
por: Cliver, Dean O.
Publicado: (2009)

Detection of serum antibodies to hepatitis E virus in domestic pigs in Italy using a recombinant swine HEV capsid protein
por: Ponterio, Eleonora, et al.
Publicado: (2014)

Capsid protein expression and adeno-associated virus like particles assembly in Saccharomyces cerevisiae
por: Backovic, Ana, et al.
Publicado: (2012)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments
por: Bogani, Giorgio, et al.
Publicado: (2020)

Hepatitis C Virus Hypervariable Region 1 Variants Presented on Hepatitis B Virus Capsid-Like Particles Induce Cross-Neutralizing Antibodies
por: Lange, Milena, et al.
Publicado: (2014)

Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
por: Jeoung, Hye-Young, et al.
Publicado: (2011)

PCV2 Uptake by Porcine Monocytes Is Strain-Dependent and Is Associated with Amino Acid Characteristics on the Capsid Surface
por: Ouyang, Yueling, et al.
Publicado: (2023)

Assembly and immunogenicity of baculovirus-derived infectious bronchitis virus–like particles carrying membrane, envelope and the recombinant spike proteins
por: Xu, Peng-wei, et al.
Publicado: (2015)

Establishment and application of a competitive enzyme-linked immunosorbent assay differentiating PCV2 antibodies from mixture of PCV1/PCV2 antibodies in pig sera
por: Han, Shuizhong, et al.
Publicado: (2016)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
por: Goepfert, P, et al.
Publicado: (2012)

A pseudotype baculovirus expressing the capsid protein of foot-and-mouth disease virus and a T-Cell immunogen shows enhanced immunogenicity in mice
por: Cao, Yimei, et al.
Publicado: (2011)

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles
por: Huhti, L., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vibvg71b8e53luuqob66jnr4qo